In addition, though preclinical studies have yet to report efficacy of EGFR-inhibition in the AOM model, AOM-induced tumors show increased EGFR activity [11], [12], therefore it is reasonable to hypothesize that this model will also respond to EGFR-targeted treatment. Here, EGFR is linked to infectious otitis media.